FOXA2 and metabolic dysfunction-associated steatotic liver disease: In concordance with a previous study (Liang et al., 2022; Zhang et al., 2023), we found that AST and ALT levels were increased in NAFLD mice and OA-induced HepG2 cells, which were weakened by oe-Foxa2 transfection.